Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Immune Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immune Therapeutics Inc market cap is $7,871.00.
What is the 52-week high for Immune Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immune Therapeutics Inc 52 week high is $0.01 as of January 07, 2026.
What is the 52-week low for Immune Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immune Therapeutics Inc 52 week low is $0.0001 as of January 07, 2026.
What is Immune Therapeutics Inc stock price today?
Immune Therapeutics Inc stock price today is $0.0601.
What was Immune Therapeutics Inc stock price yesterday?
Immune Therapeutics Inc stock price yesterday was $0.07.
What is the 50-day moving average of Immune Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immune Therapeutics Inc 50-day moving average is $0.0001.